Recently, it emerged that bone is an important endocrine organ that regulates energy metabolism through osteocalcin, a hormone that favours insulin secretion and sensitivity, and energy expenditure. According to the general rules of endocrinology, these observations suggested that insulin might in turn affect the endocrine function of bones. To address this issue, Ferron et al. engineered an osteoblast-specific insulin-receptor-deficient mouse model and demonstrated that maintenance of whole-body glucose homeostasis requires insulin signalling in osteoblasts. Insulin signalling in osteoblasts essentially hijacks the functional interaction that exists in bone between osteoblasts and osteoclasts. In osteoblasts, insulin signalling inhibits the expression of an inhibitor of bone resorption, thereby upregulating this function. Osteoclasts resorb bone under highly acidic conditions, providing a favourable environment for the activation of osteocalcin, which, in turn, stimulates insulin secretion. This mechanism occurs in mice and in humans. These results further underscore the tight relationship that has emerged recently between bone physiology and glucose homeostasis; they also have important implications for the treatment of diseases such as type 2 diabetes and osteoporosis.
Boning up on energy metabolism
Boning up on energy metabolism. Dis Model Mech 1 September 2010; 3 (9-10): 506. doi:
Download citation file:
Advertisement
Cited by
Special Issue: The RAS Pathway

Our latest special issue is now complete. It showcases RAS-driven mechanisms of disease progression, and highlights approaches to treat and modify the disease course in model systems.
Call for papers: Moving Heart Failure to Heart Success

Disease Models & Mechanisms is pleased to welcome submissions for consideration for an upcoming special issue, Moving Heart Failure to Heart Success: Mechanisms, Regeneration & Therapy. The deadline for submitting articles to the special issue has been extended to 1 August 2022.
Propose a new Workshop

Our Workshops bring together leading experts and early-career researchers from a range of scientific backgrounds. Applications are now open to propose Workshops for 2024, one of which will be held in a Global South country. .
A focus on Drosophila

In a series of front section articles, DMM is highlighting the versatility, breadth, and scope of Drosophila research in human disease modelling and translational medicine.
Apply for a DMM Conference Travel Grant

Aimed at early-career researchers wanting to attend in-person and virtual meetings, the next application deadline for a DMM Conference Travel Grant is 6 June 2022. Find out more and hear from past recipients about their experience of the grant.
Other journals from
The Company of Biologists